NCT01958710|Unknown
Outcome After Treatment of Pulmonary Aspergilloma
Outcome After Surgical Treatment or Bronchial Embolisation in Aspergilloma of the Lung: a Single Center Experience.
Loading search results
Outcome After Surgical Treatment or Bronchial Embolisation in Aspergilloma of the Lung: a Single Center Experience.
Sponsor study identifier
observational
100
1 country
1
Study Start
October 2013
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
April 2014
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
June 2014
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Retrospective analysis of surgery and/or bronchial embolisation for pulmonary aspergilloma.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
June 2014
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
October 2013
Date type not reportedThis date has not been verified as actual or estimated.
October 7, 2013
Actual (reported)October 9, 2013
Actual (reported)April 2014
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
June 2014
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
survival after treatment
estimated 10 yaer survival after treatment for pulmonary aspergilloma
10 years
post treatment survival
90 days
(preoperative) embolisation of the bronchial circulation
Any surgically treated patient with a functional lung resection (at least wedge resection)
All patients in the database with following interventions will be screened for invasive aspergilloma in the final resection specimen: Aspergilloma Fungal disease Lung bleeding Destroyed lung Empyema of the lung
University Hospital Leuven
Leuven, 3000, Belgium
Herbert Decaluwé, MD
UZ Leuven - dept. Thoracic Surgery
Laurence Bertrand, MSc
Katholic University Leuven
First Submitted
October 7, 2013
First Posted
October 9, 2013
Study Start
October 2013
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
April 2014
Contact the study team to confirm eligibility.
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
June 2014
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
October 9, 2013
Record last verified: 2013-10
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: